Education
About Us
Working with TipRanks
Follow Us
Pfizer (DE:PFE)
XETRA:PFE
Ipilimumab, Pf-08634404
Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma, Carcinoma, Hepatocellular, Unresectable Hepatocellular Carcinoma, Liver Neoplasms
Phase I/II
Recruiting
A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Nov 07, 2025
―
Midazolam, Pf-08049820, Dabigatran Etexilate, Portia (Ee And Ln) Or Equivalent Oral Tablet
Atopic Dermatitis
Phase I
Active Not Recruiting
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
Sep 02, 2025
Pf-08049820 Mr1, Pf-08049820 Mr2, Pf-08049820 Ir
Atopic Dermatitis
Phase I
Active Not Recruiting
A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
Aug 28, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pfizer (PFE) have in its pipeline
PFE is currently developing the following drugs: Pf-07985631, Ipilimumab, Pf-08634404, Ritlecitinib 100 Mg, Ritlecitinib 50 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.